{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:49:30Z","timestamp":1778262570017,"version":"3.51.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK125350-02"],"award-info":[{"award-number":["R01DK125350-02"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Our understanding of ANCA vasculitis has advanced from discovery of putative auto-antibodies to a greater understanding of the myriad alterations of innate and adaptive immunity in this disease. The 21st International Vasculitis Workshop held in Barcelona served again as a forum for distributing and sharing advances in this field. B-cell and T-cell subsets are skewed in ANCA vasculitis patients, favoring a pro-inflammatory phenotype. Autoantigen expression of myeloperoxidase (MPO) and proteinase-3 (PR3) is influenced by alterations in chromatin modifications. Changes in DNA methylation may predict the likelihood of sustained remission in vasculitis patients. As our knowledge of disease pathogenesis and disease persistence have progressed, so too has our therapeutic armamentarium. Treatment options are emerging across a variety of immune targets, including the innate and adaptive immune system. Monoclonal antibodies targeting interleukins are available as are complement inhibitors that target the innate immune system. Addressing innate immune responses may be important to abate acute inflammatory responses at disease onset and limit subsequent damage, especially in patients with glomerulonephritis. With expanding therapeutic options, an important consideration remains as to when to stop therapy. A subset of patients discontinue therapy and remain off treatment without relapse, a state of long-term remission off therapy (LTROT). Future therapeutics could be derived from understanding the underlying immunological phenotype in LTROT and developing targeted therapies for durable remission without global immunosuppression. Management of ANCA vasculitis is moving rapidly towards more targeted, less toxic therapies that will optimistically lead to preservation, and perhaps restoration of health.<\/jats:p>","DOI":"10.1093\/rheumatology\/keae613","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:18:06Z","timestamp":1741771086000},"page":"i2-i10","source":"Crossref","is-referenced-by-count":1,"title":["The evolving landscape of vasculitis management: past, current and emerging"],"prefix":"10.1093","volume":"64","author":[{"given":"Ronald J","family":"Falk","sequence":"first","affiliation":[{"name":"UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan E","family":"Free","sequence":"additional","affiliation":[{"name":"UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic J","family":"Ciavatta","sequence":"additional","affiliation":[{"name":"UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruti P","family":"Chen","sequence":"additional","affiliation":[{"name":"UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimal K","family":"Derebail","sequence":"additional","affiliation":[{"name":"UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025031209171180900_keae613-B1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2025031209171180900_keae613-B2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"Van Der Woude","year":"1985","journal-title":"Lancet"},{"key":"2025031209171180900_keae613-B3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"2025031209171180900_keae613-B4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","article-title":"Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils","volume":"84","author":"Goldschmeding","year":"1989","journal-title":"J Clin Invest"},{"key":"2025031209171180900_keae613-B5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B7","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"ProcNatlAcadSciUSA"},{"key":"2025031209171180900_keae613-B8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"2025031209171180900_keae613-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0b013e32834d2d52","article-title":"Animal models of antineutrophil cytoplasm antibody-associated vasculitis","volume":"24","author":"Salama","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2025031209171180900_keae613-B10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2025031209171180900_keae613-B11","first-page":"448","article-title":"T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)","volume":"98","author":"Brouwer","year":"1994","journal-title":"ClinExpImmunol"},{"key":"2025031209171180900_keae613-B12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2249.1996.d01-629.x","article-title":"T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis","volume":"103","author":"Griffith","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2025031209171180900_keae613-B13","first-page":"539","article-title":"T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission","volume":"112","author":"King","year":"1998","journal-title":"ClinExpImmunol"},{"key":"2025031209171180900_keae613-B14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2008.309","article-title":"ANCA patients have T cells responsive to complementary PR-3 antigen","volume":"74","author":"Yang","year":"2008","journal-title":"Kidney Int"},{"key":"2025031209171180900_keae613-B15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.10384","article-title":"In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase","volume":"46","author":"Popa","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B16","first-page":"1825","article-title":"Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis","volume":"21","author":"Marinaki","year":"2006","journal-title":"NephrolDialTransplant"},{"key":"2025031209171180900_keae613-B17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1196\/annals.1381.003","article-title":"CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis","volume":"1107","author":"Abdulahad","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"2025031209171180900_keae613-B18","doi-asserted-by":"crossref","first-page":"e5287","DOI":"10.1371\/journal.pone.0005287","article-title":"CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients","volume":"4","author":"Ordonez","year":"2009","journal-title":"PLoSOne"},{"key":"2025031209171180900_keae613-B19","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.37959","article-title":"ANCA-associated vasculitis patients have defective Treg function exacerbated by presence of a suppression-resistant effector population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B20","doi-asserted-by":"crossref","first-page":"e18734","DOI":"10.1371\/journal.pone.0018734","article-title":"Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Rimbert","year":"2011","journal-title":"PLoS One"},{"key":"2025031209171180900_keae613-B21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2567.2009.03213.x","article-title":"Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells","volume":"130","author":"Morgan","year":"2010","journal-title":"Immunology"},{"key":"2025031209171180900_keae613-B22","doi-asserted-by":"crossref","first-page":"E2615","DOI":"10.1073\/pnas.1210147109","article-title":"The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis","volume":"109","author":"Ooi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025031209171180900_keae613-B23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1681\/ASN.2015121356","article-title":"CD8+ T cells effect glomerular injury in experimental anti-myeloperoxidase GN","volume":"28","author":"Chang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B24","doi-asserted-by":"crossref","first-page":"102306","DOI":"10.1016\/j.jaut.2019.102306","article-title":"Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis","volume":"106","author":"Free","year":"2020","journal-title":"J Autoimmun"},{"key":"2025031209171180900_keae613-B25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2021081142","article-title":"Immunological interaction of HLA-DPB1 and proteinase 3 in ANCA vasculitis is associated with clinical disease activity","volume":"33","author":"Chen","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B26","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","article-title":"Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"key":"2025031209171180900_keae613-B27","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/rheumatology\/keaa432","article-title":"Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis","volume":"60","author":"London","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025031209171180900_keae613-B28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2215\/CJN.03950412","article-title":"Decreased CD5+ B cells in active ANCA vasculitis and relapse after rituximab","volume":"8","author":"Bunch","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.12483","article-title":"Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies","volume":"180","author":"Aybar","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2025031209171180900_keae613-B30","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/annrheumdis-2014-206756","article-title":"Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis","volume":"74","author":"Bunch","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025031209171180900_keae613-B31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/01.ASN.0000135058.46193.72","article-title":"Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"15","author":"Yang","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.ki.5002371","article-title":"Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis","volume":"72","author":"Alcorta","year":"2007","journal-title":"Kidney Int"},{"key":"2025031209171180900_keae613-B33","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.27398","article-title":"Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis","volume":"62","author":"Cheadle","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B34","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.39153","article-title":"Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"67","author":"Grayson","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025031209171180900_keae613-B35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2009.108043","article-title":"Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis","volume":"69","author":"Lyons","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025031209171180900_keae613-B36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.2005.02819.x","article-title":"Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis","volume":"141","author":"Ohlsson","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2025031209171180900_keae613-B37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1681\/ASN.2013101092","article-title":"Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis","volume":"26","author":"McInnis","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B38","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.kint.2020.04.037","article-title":"ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation","volume":"98","author":"Jones","year":"2020","journal-title":"Kidney Int"},{"key":"2025031209171180900_keae613-B39","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta","year":"2010","journal-title":"J Clin Invest"},{"key":"2025031209171180900_keae613-B40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13148-016-0251-0","article-title":"Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis","volume":"8","author":"Yang","year":"2016","journal-title":"Clin Epigenetics"},{"key":"2025031209171180900_keae613-B41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1681\/ASN.2016050548","article-title":"Gene-specific DNA methylation changes predict remission in patients with ANCA-associated vasculitis","volume":"28","author":"Jones","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B42","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/ndt\/gfad090","article-title":"Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines\/recommendations","volume":"38","author":"Casal Moura","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025031209171180900_keae613-B43","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"2025031209171180900_keae613-B44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI113710","article-title":"Analysis of renal fibrosis in a rabbit model of crescentic nephritis","volume":"82","author":"Downer","year":"1988","journal-title":"J Clin Invest"},{"key":"2025031209171180900_keae613-B45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","article-title":"Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Hogan","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2215\/CJN.02500317","article-title":"ANCA Glomerulonephritis and Vasculitis","volume":"12","author":"Jennette","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"NEnglJ Med"},{"key":"2025031209171180900_keae613-B48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB115 Allele Is a Risk Factor for PR3-ANCA Disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B49","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med"},{"key":"2025031209171180900_keae613-B51","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025031209171180900_keae613-B52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2025031209171180900_keae613-B53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2025031209171180900_keae613-B54","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"2025031209171180900_keae613-B55","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2019-216863","article-title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","volume":"79","author":"Smith","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025031209171180900_keae613-B56","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2021030382","article-title":"The clinical application of urine soluble CD163 in ANCA-associated vasculitis","volume":"32","author":"Moran","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2025031209171180900_keae613-B57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166107","article-title":"PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"2025031209171180900_keae613-B58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ekir.2019.01.004","article-title":"Understanding Long-term remission off therapy in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"4","author":"Hogan","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2025031209171180900_keae613-B59","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9010083","article-title":"Therapeutic targeting of autoreactive B cells: why, how, and when?","volume":"9","author":"Stensland","year":"2021","journal-title":"Biomedicines"},{"key":"2025031209171180900_keae613-B60","doi-asserted-by":"crossref","first-page":"103266","DOI":"10.1016\/j.jaut.2024.103266","article-title":"Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice","volume":"147","author":"Hu","year":"2024","journal-title":"J Autoimmun"},{"key":"2025031209171180900_keae613-B61","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1002\/cti2.1250","article-title":"Natural killer cells in inflammatory autoimmune diseases","volume":"10","author":"Yang","year":"2021","journal-title":"Clin Transl Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/Supplement_1\/i2\/62374908\/keae613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/Supplement_1\/i2\/62374908\/keae613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:18:21Z","timestamp":1741771101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/Supplement_1\/i2\/8069399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":61,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae613","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3,1]]}}}